24061
| Randomized phase II feasibility study of Cetuximab combined with 4 cycles of TPF followed by platinum based chemo-radiation strategies |
24051
| Phase I/II study on induction chemotherapy followed by chemoradiation with or without lapatinib, a dual EGFR/ErbB2 kinase inhibitor, in patients with locally advanced resectable larynx and hypopharynx squamous cell. |
24001
| Randomized phase III study on the selection of the target volume in postoperative radiotherapy for cervical lymph node metastases of squamous cell carcinoma from an unknown primary (CUP) |
24981
| A feasibility study of primary chemotherapy followed by concomitant chemoradiation with or without amifostine in patients with locally advanced
undifferenciated nasopharyngeal cancer (UNPC). |
24982
| Phase II study on Gemcitabine in Recurrent or Metastatic
Adenoid Cystic Carcinoma of the Head and Neck |
22996
| A phase III double-blind, randomized, placebo-controlled study
of Erythropoietin when used as an adjuvant to radiation therapy
in patients with head and neck squamous cell carcinoma.
EORTC 22996-24002
|
24971
| A randomized phase III multicenter trial of neoadjuvant docetaxel (Taxotere)
plus cisplatin plus 5-fluorouracil versus neoadjuvant cisplatin plus
5-fluorouracil in patients with locally advanced inoperable squamous cell
carcinoma of the head and neck
|
24954
| Phase III study on larynx preservation comparing induction chemotherapy and
radiotherapy versus alternating chemo-radiotherapy in resectable hypopharynx
and larynx cancers (Jointly with the EORTC Radiotherapy Cooperative Group) |
24941
| A randomized phase III study of supportive care plus Methotrexate versus supportive care only in patients with metastatic or recurrent squamous cell carcinoma of the head and neck |
24922
| Randomized phase II trial of Methotrexate vs two schedules of Taxol in patients with advanced squamous cell carcinoma of the head and neck |
24921
| Phase II study of Interferon alpha and 5-fluorouracil in locally advanced or recurrent or metastatic squamous cell carcinoma of the head and neck |
24891
| Is laryngeal preservation with induction chemotherapy safe in the treatment of hypopharyngeal squamous cell carcinoma ? A randomized phase III trial |
24882
| Phase II study of mitoxantrone in recurrent or metastatic adenoid cystic carcinoma of the head and neck |
24881
| Phase II study of Epirubicin and Cisplatin in advanced nasopharyngeal carcinoma (NFC) |
24873
| PHASE II STUDY OF PIRARUBICIN (THP) IN PATIENTS WITH ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK. |
24872
| Randomized phase III trial of methotrexate vs 10-EdAm, a new methotrexate analogue,in patients with advanced squamous cell carcinoma of the head and neck |
24871
| EUROSCAN: Phase III randomized trial of chemoprevention with vitamin A and N-acetylcysteine in patients curatively treated for carcinomas of the larynx, oral cavity and lung. (Jointly with the EORTC Lung Cancer Cooperative Group : Protocol 08871) |
24861
| Phase III Randomized Comparison of Chemotherapy with CDDP/5-FU Followed by Radiotherapy vs Radical Surgery with or without Radiotherapy in Patients with Nonmetastatic Squamous Cell Carcinoma of the Larynx |
24863
| Phase II Randomized Chemotherapy Trial of CHIP vs CACP in Patients with Advanced Ovarian Cancer Refractory or Recurrent After First-Line Chemotherapy with CBDCA (Summary Last Modified 05/88 |
24851
| PHASE II STUDY OF 4'-EPIDoxorubicin IN RECURRENT OR METASTATIC ADENOID CYSTIC CARCINOMA OF THE HEAD AND NECK. |
24844
| 5-FU/CDDP FOLLOWED BY SURGERY AND RADIOTHERAPY vs SURGERY AND RADIOTHERAPY IN ADVANCED SQUAMOUS CELL CARCINOMA OF LATERAL OROPHARYNX AND LATERAL POSTERIOR ORAL CAVITY (Phase III trial) |
24842
| Randomized trial of cisplatin, methotrexate, bleomycin and vincristine (CABO) vs cisplatin and 5-fluorouracil (CF) vs cisplatine alone (C) in patients with advanced squamous cell carcinoma of the head and neck. |
24801
| Phase II trial of vindesine in continuous infusion in advanced squamous cell carcinoma of the head and neck |
24813
| Phase II trial of a combination of hydroxyurea, 5-fluorouracil, and mitomycin C in advanced squamous cell carcinoma of the head and neck |
24814
| Phase III trial comparing a combination of cisplatin, methotrexate, bleomycin, vincristine (CABO) versus a combination of methotrexate, bleomycin, vincristine (ABO) in recurrent or metastatic squamous cell carcinoma of the head and neck |
24815
| Phase II study of a combination of cisplatin and 5-fluorouracil as second-line chemotherapy regimen in recurrent or metastatic squamous cell carcinoma of the head and neck |
24841
| Phase II study of 9-hydroxy-2N-methyl-ellipticinium in recurrent or metastatic adenoid cystic carcinoma of the head and neck |
24803BB
| Phase III trial comparing methotrexate versus methotrexate alternated with vinblastine plus bleomycin after initial radiotherapy for locally advanced oropharyngeal carcinomas
|
24843BB
| Controlled study on preoperative intra-arterial infusions of vincristine + bleomycin prior to surgery for epidermoid carcinomas of the floor of the mouth (oral cavity # 2)
|
24751BB
| Intra-arterial MTX vs BLM for advanced carcinomas of the oral cavity - sequential study
|
24752BB
| Randomized study for advanced oropharynx carcinomas treated by telecobalt and systemic BLM + telecobalt
|
24753BB
| Clinical trial on combined radiations and maintenance chemotherapy for loco-regionally advanced nasopharynx carcinomas
|
24761BB
| Trial NPC # 2 - Trial on long term chemotherapy (ADM alone vs ADM + VLB + BLM) in advanced nasopharyngeal carcinomas
|
24772BB
| Trial oral cavity # 1 - Intra-arterial MTX vs BLM for advanced carcinomas of the oral cavity - sequential study
|
24773BB
| Trial oral cavity # 2 - Intra-arterial BLM vs BLM + VCR + MTX for advanced carcinoma of the oral cavity
|
24774BB
| Pilot study on polychemotherapy for advanced head and neck carcinomas not operable nor irradiable
|
24781BB
| Evaluation of long term chemotherapy (MTX versus MTX alternated with VLB + BLM) after initial radiotherapy for locally advanced oropharyngeal carcinomas
|
24771
| Phase III trial of prior polychemotherapy (vincristine-bleomycin-methotrexate) or not before combined surgery and irradiation for advanced epitheliomas of the pyriform sinus |
24791
| Phase II trial of a combination of methotrexate-bleomycin-cisplatin and vincristine in metastatic or locally recurrent squamous cell carcinoma of the head and neck |
90111
| Neoadjuvant afatinib based treatment strategies followed by surgery in squamous cell carcinoma of the head and neck: an EORTC NOCI-HNCG window study |
